Back
Recovery & HRVCardio fitnessCycle

Omega-3 (EPA+DHA)

DHA-forward fish or algal oil

StrongLikely visible in your data
3
sources
137
trials
4,973
participants (largest study)
1
study designs
The verdict

The largest meta-analysis on the topic — 51 trials — found omega-3 lowers resting heart rate by about 2 beats per minute, an effect driven by DHA rather than EPA. Fish-oil trials also increase vagally-mediated heart-rate variability. This is one of the few supplement effects large and steady enough to see in a wearable's resting-heart-rate trend over two to three months.

Why this grade
Emerging
Preliminary or mechanistic
Moderate
Some RCTs, limited replication
Strong
Multiple RCTs or meta-analyses, consistent direction

Strong: 51 RCTs with ~3,000 participants, a clear dose–response for blood pressure across 71 RCTs, and mechanistic coherence (membrane effects on sinus-node cells). Effect sizes are modest but highly consistent.

How it works

DHA incorporates into cardiac cell membranes, slowing pacemaker cells and shifting autonomic balance toward the parasympathetic side.

Who it helps, and who it doesn't

Anyone with a low omega-3 index; DHA-forward oils for heart-rate effects; 4–12 weeks to see it. Keep to ≤3 g/day — higher prescription doses carry an atrial-fibrillation signal.

Measured effects (absolute, from the trials)

Every estimate, against a line of no effect

Diamonds are point estimates; the hairline is the 95% confidence interval where the trial reported one.

  • Resting heart rate
    bpm · Hidayat 2018
    −2.23
    −3.07 … −1.40
  • Resting heart rate (DHA-only trials)
    bpm · Hidayat 2018
    −2.47
    [not reported]
−3−2−10NO EFFECT
Separate scale · mmHg
  • Systolic blood pressure (2–3 g/day)
    mmHg · Zhang 2022
    −2.00
    [not reported]
  • Systolic BP in hypertensives
    mmHg · Zhang 2022
    −4.50
    [not reported]
−4−20NO EFFECT

Units are never mixed on one line: each scale gets its own axis. Where a trial reported no confidence interval we leave it blank rather than inventing one.

Will you see it in your wearable?

We compare each effect to the typical night-to-night noise of that metric. Effects smaller than the noise are real but invisible in a week of data.

  • Resting heart rateLikely visible
    effect: 2.23 bpmnightly noise: ±2 bpm
  • Resting heart rate (DHA-only trials)Likely visible
    effect: 2.47 bpmnightly noise: ±2 bpm
Studies over time

3 studies across 9 years

20132022
20132015201820202022
Meta-analysis or systematic reviewRandomized or crossover trialObservational or preliminaryHover a marker for detail
Dose
1–3 g/day EPA+DHA
Timing
With a fat-containing meal; 4–12 weeks to effect
Safety flags
  • · Mild bleeding-time increase — caution with anticoagulants; stop 2 weeks pre-surgery.
  • · Atrial fibrillation signal at ≥4 g/day — stay ≤3 g.

References

  1. 1.
    Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials
    European Journal of Clinical Nutrition · 2018 · meta-analysis · 51 trials · n = 3,000

    Heart rate −2.23 bpm (95% CI −3.07 to −1.40); DHA −2.47 bpm; EPA alone no effect.

  2. 2.
    Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials
    American Journal of Clinical Nutrition · 2013 · meta-analysis · 15 trials

    Increased high-frequency (vagal) HRV with fish oil.

  3. 3.
    Omega-3 polyunsaturated fatty acids intake and blood pressure: a dose-response meta-analysis of randomized controlled trials
    Journal of the American Heart Association · 2022 · meta-analysis · 71 trials · n = 4,973

    Optimal BP reduction at 2–3 g/day EPA+DHA; larger in hypertensive participants.

Umbral is a wellness product, not a medical device. It does not diagnose, treat, cure or prevent any disease. Supplement information is educational; talk to a clinician before starting anything, especially if you are pregnant, under 18, managing a condition or taking medication.